Glaucocalyxin B Attenuates Ovarian Cancer Cell Growth and Cisplatin Resistance In Vitro via Activating Oxidative Stress

por Zhang, Tingting, Xu, Chenxin, Zheng, Peisen, Zhang, Xiaoxian, Qiu, Chenyu, Wu, Fengjiao, Chen, Jundixia, Xiao, Zhongxiang, Zhu, Jiandong, Zhang, Jingjing, Zou, Peng, Ni, Daoyong
Publicado 2022

Combination therapy with HSP90 inhibitors and piperlongumine promotes ROS-mediated ER stress in colon cancer cells

por Qiu, Chenyu, Shen, Xin, Lu, Hui, Chen, Yinghua, Xu, Chenxin, Zheng, Peisen, Xia, Yiqun, Wang, Junqi, Zhang, Yafei, Li, Shaotang, Zou, Peng, Cui, Ri, Chen, Jundixia
Publicado 2023

Isodeoxyelephantopin Inactivates Thioredoxin Reductase 1 and Activates ROS-Mediated JNK Signaling Pathway to Exacerbate Cisplatin Effectiveness in Human Colon Cancer Cells

por Hong, Lin, Chen, Jundixia, Wu, Fang, Wu, Fengjiao, Shen, Xin, Zheng, Peisen, Shao, Rongrong, Lu, Kongqin, Liu, Zhiguo, Chen, Daoxing, Liang, Guang, Cai, Yuepiao, Zou, Peng, Xia, Yiqun
Publicado 2020

Compensatory combination of mTOR and TrxR inhibitors to cause oxidative stress and regression of tumors

por Xia, Yiqun, Chen, Jundixia, Yu, Yun, Wu, Fengjiao, Shen, Xin, Qiu, Chenyu, Zhang, Tingting, Hong, Lin, Zheng, Peisen, Shao, Rongrong, Xu, Chenxin, Wu, Fang, Chen, Wei, Xie, Congying, Cui, Ri, Zou, Peng
Publicado 2021